87 related articles for article (PubMed ID: 9832951)
1. Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis.
Dehpour AR; Akbarloo N; Ghafourifar P
Behav Pharmacol; 1998 Feb; 9(1):77-80. PubMed ID: 9832951
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis.
Ghafourifar P; Dehpour AR; Akbarloo N
Life Sci; 1997; 60(19):PL 265-70. PubMed ID: 9129128
[TBL] [Abstract][Full Text] [Related]
3. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
Borhani AA; Houshmand G; Samini M; Namiranian K; Hajrasouliha AR; Tavakoli S; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2005 May; 514(2-3):183-9. PubMed ID: 15910805
[TBL] [Abstract][Full Text] [Related]
4. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
Zarrindast MR; Asgari-Afshar A; Sahebgharani M
Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
[TBL] [Abstract][Full Text] [Related]
5. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
Ebrahimi F; Tavakoli S; Hajrasouliha AR; Shafaroodi H; Sadeghipour H; Riazi K; Borhani AA; Houshmand G; Ahmadi SH; Dehpour AR
Eur J Pharmacol; 2005 Oct; 523(1-3):93-100. PubMed ID: 16226248
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
[TBL] [Abstract][Full Text] [Related]
7. Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice.
Nasehi M; Piri M; Abbolhasani K; Zarrindast MR
Behav Pharmacol; 2013 Jun; 24(3):180-94. PubMed ID: 23604167
[TBL] [Abstract][Full Text] [Related]
8. Litter has an effect on the behavioural changes caused by the administration of the nitric oxide synthase inhibitor NG-nitro-L-arginine and ethanol in mice.
Okva K; Lang A; Pokk P; Väli M; Nevalainen T
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1171-9. PubMed ID: 15610930
[TBL] [Abstract][Full Text] [Related]
9. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
Cao JL; Liu HL; Wang JK; Zeng YM
Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress.
Abdel-Zaher AO; Abdel-Rahman MS; Elwasei FM
Neurotoxicology; 2011 Dec; 32(6):725-33. PubMed ID: 21855572
[TBL] [Abstract][Full Text] [Related]
11. Alteration in male reproductive system in experimental cholestasis: roles for opioids and nitric oxide overproduction.
Kiani S; Valizadeh B; Hormazdi B; Samadi H; Najafi T; Samini M; Dehpour AR
Eur J Pharmacol; 2009 Aug; 615(1-3):246-51. PubMed ID: 19445924
[TBL] [Abstract][Full Text] [Related]
12. Resistance to depression through interference of opioid and nitrergic systems in bile-duct ligated mice.
Haj-Mirzaian A; Hamzeh N; Javadi-Paydar M; Abdollahzadeh Estakhri MR; Dehpour AR
Eur J Pharmacol; 2013 May; 708(1-3):38-43. PubMed ID: 23528353
[TBL] [Abstract][Full Text] [Related]
13. The effect of the serotonergic system on opioid withdrawal-like syndrome in a mouse model of cholestasis.
Dehpour AR; Sadeghipour HR; Nowroozi A; Akbarloo N
Hum Psychopharmacol; 2000 Aug; 15(6):423-428. PubMed ID: 12404304
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome.
London ED; Kimes AS; Vaupel DB
NIDA Res Monogr; 1995; 147():170-81. PubMed ID: 8742786
[TBL] [Abstract][Full Text] [Related]
15. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Mori T; Ito S; Matsubayashi K; Sawaguchi T
Behav Pharmacol; 2007 Dec; 18(8):725-9. PubMed ID: 17989510
[TBL] [Abstract][Full Text] [Related]
17. Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide.
Tavakoli S; Hajrasouliha AR; Jabehdar-Maralani P; Ebrahimi F; Sadeghipour H; Dehghani M; Shafaroodi H; Dehpour AR
Eur J Pharmacol; 2006 Aug; 542(1-3):148-53. PubMed ID: 16824510
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide in catalepsy and hyperthermia in morphine-dependent rats.
Afify EA; Daabees TT; Gabra BH; Abou Zeit-Har MS
Pharmacol Res; 2001 Dec; 44(6):533-9. PubMed ID: 11735362
[TBL] [Abstract][Full Text] [Related]
19. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
Naidu PS; Singh A; Joshi D; Kulkarni SK
Addict Biol; 2003 Sep; 8(3):327-36. PubMed ID: 13129835
[TBL] [Abstract][Full Text] [Related]
20. Resistance of cholestatic rats against epinephrine-induced arrhythmia: the role of nitric oxide and endogenous opioids.
Hajrasouliha AR; Tavakoli S; Jabehdar-Maralani P; Shafaroodi H; Borhani AA; Houshmand G; Sadeghipour H; Dehghani M; Dehpour AR
Eur J Pharmacol; 2004 Sep; 499(3):307-13. PubMed ID: 15381053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
